Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A18171 | 27309736 | Horm Res Paediatr | Serum Pentraxin 3 Fragment as a Noninvasive Marker of Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents. | 2016 | Details |
| A18173 | 27308959 | Scand J Gastroenterol | Feasibility of liver stiffness measurement in morbidly obese patients undergoing bariatric surgery using XL probe. | 2016 | Details |
| A18175 | 27308649 | J Gastrointestin Liver Dis | Real-life Perception and Practice Patterns of NAFLD/NASH in Romania: Results of a Survey Completed by 102 Board-certified Gastroenterologists. | 2016 | Details |
| A18178 | 27308646 | J Gastrointestin Liver Dis | Small Intestinal Bacterial Overgrowth Is Associated with Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A18184 | 27305420 | Arq Gastroenterol | NONALCOHOLIC FATTY LIVER DISEASE BRAZILIAN SOCIETY OF HEPATOLOGY CONSENSUS. | 2017 | Details |
| A18185 | 27304953 | Int J Mol Sci | Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials. | 2016 | Details |
| A18188 | 27301803 | Metabolism | Pharmacological management of nonalcoholic fatty liver disease. | 2016 | Details |
| A18193 | 27296438 | BMC Gastroenterol | Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine. | 2016 | Details |
| A18200 | 27288988 | Hepatol Res | Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection. | 2016 | Details |
| A18203 | 27288299 | Clin Res Hepatol Gastroenterol | Screening for rare variants in the PNPLA3 gene in obese liver biopsy patients. | 2016 | Details |
| A18204 | 27288055 | J Endocrinol | Metformin increases hepatic leptin receptor and decreases steatosis in mice. | 2016 | Details |
| A18205 | 27287838 | Orv Hetil | [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016]. | 2016 | Details |
| A18212 | 27282405 | J Mol Cell Biol | Deletion of Gab2 in mice protects against hepatic steatosis and steatohepatitis: a novel therapeutic target for fatty liver disease. | 2016 | Details |
| A18223 | 27276398 | Clinics (Sao Paulo) | Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey. | 2016 | Details |
| A18228 | 27272667 | Obes Surg | Influence of Liver Disease on Perioperative Outcome After Bariatric Surgery in a Northern German Cohort. | 2017 | Details |
| A18235 | 27266339 | J Med Food | Hepatoprotective Effects of Soybean Embryo by Enhancing Adiponectin-Mediated AMP-Activated Protein Kinase α Pathway in High-Fat and High-Cholesterol Diet-Induced Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18252 | 27262844 | Dig Dis Sci | Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18253 | 27262842 | Acta Biochim Pol | Hepatokines and non-alcoholic fatty liver disease. | 2016 | Details |
| A18254 | 27262247 | J Fam Pract | Non-alcoholic fatty liver disease: What's in our arsenal? | 2016 | Details |
| A18256 | 27261901 | Gastroenterol Clin North Am | Obesity in Women: The Clinical Impact on Gastrointestinal and Reproductive Health and Disease Management. | 2016 | Details |
| A18257 | 27261776 | Mol Med | Activation of proteinase 3 contributes to Non-alcoholic Fatty Liver Disease (NAFLD) and insulin resistance. | 2016 | Details |
| A18258 | 27261415 | J Hepatol | A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer. | 2016 | Details |
| A18266 | 27255583 | J Hepatol | Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver. | 2016 | Details |
| A18267 | 27254774 | Liver Int | ADAMTS5 deficiency protects against non-alcoholic steatohepatitis in obesity. | 2016 | Details |
| A18269 | 27252820 | Middle East J Dig Dis | The Prevalence of Metabolic Syndrome In Non-alcoholic Fatty Liver Disease; A Population-Based Study. | 2016 | Details |
| A18275 | 27248665 | Oncotarget | Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females. | 2016 | Details |
| A18276 | 27248435 | Curr Protoc Mouse Biol | Development of a Representative Mouse Model with Nonalcoholic Steatohepatitis. | 2016 | Details |
| A18277 | 27248434 | Curr Protoc Mouse Biol | An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present. | 2016 | Details |
| A18280 | 27246655 | Sci Rep | Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance. | 2016 | Details |
| A18291 | 27237782 | Pediatr Obes | An assessment of racial differences in the upper limits of normal ALT levels in children and the effect of obesity on elevated values. | 2016 | Details |
| A18292 | 27237577 | Metabolism | Non-alcoholic fatty liver disease and dyslipidemia: An update. | 2016 | Details |
| A18301 | 27227687 | Eur J Gastroenterol Hepatol | Adaptation of liver stiffness measurement depth in bariatric surgery candidates with suspected nonalcoholic fatty liver disease. | 2016 | Details |
| A18307 | 27222533 | Gut | Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption. | 2016 | Details |
| A18310 | 27220852 | Obes Surg | Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese. | 2017 | Details |
| A18313 | 27219496 | Endocr Pract | AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. | 2016 | Details |
| A18316 | 27216820 | Int J Obes (Lond) | Adiponectin mediates the additive effects of combining daily exercise with caloric restriction for treatment of non-alcoholic fatty liver. | 2016 | Details |
| A18321 | 27213358 | Int J Mol Sci | The Natural Course of Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A18325 | 27211602 | Surgery | Factors that predict the occurrence of and recovery from non-alcoholic fatty liver disease after pancreatoduodenectomy. | 2016 | Details |
| A18326 | 27208776 | Biochem Biophys Res Commun | GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway. | 2016 | Details |
| A18327 | 27207512 | Diabetes | Variants in Genes Controlling Oxidative Metabolism Contribute to Lower Hepatic ATP Independent of Liver Fat Content in Type 1 Diabetes. | 2016 | Details |
| A18328 | 27207510 | Diabetes | Lipodystrophy Due to Adipose Tissue-Specific Insulin Receptor Knockout Results in Progressive NAFLD. | 2016 | Details |
| A18329 | 27207181 | Dig Dis Sci | Effect of Intragastric Balloons on Liver Enzymes: A Systematic Review and Meta-Analysis. | 2016 | Details |
| A18332 | 27200103 | Evid Based Complement Alternat Med | A Fomitopsis pinicola Jeseng Formulation Has an Antiobesity Effect and Protects against Hepatic Steatosis in Mice with High-Fat Diet-Induced Obesity. | 2016 | Details |
| A18341 | 27196572 | Gut | Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism. | 2016 | Details |
| A18348 | 27188904 | Nutr Res | Alternate-day fasting protects the livers of mice against high-fat diet-induced inflammation associated with the suppression of Toll-like receptor 4/nuclear factor κB signaling. | 2016 | Details |
| A18350 | 27187452 | Nutrients | Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals. | 2016 | Details |
| A18351 | 27187365 | Int J Mol Sci | Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers. | 2016 | Details |
| A18352 | 27185609 | Lancet Diabetes Endocrinol | Phenotypes of prediabetes and stratification of cardiometabolic risk. | 2016 | Details |
| A18355 | 27185080 | Am J Gastroenterol | Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18356 | 27184920 | Sci Rep | Preventing High Fat Diet-induced Obesity and Improving Insulin Sensitivity through Neuregulin 4 Gene Transfer. | 2016 | Details |
| A18360 | 27183219 | Hepatol Res | Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis. | 2016 | Details |
| A18365 | 27180240 | Toxicol Appl Pharmacol | Activation of the Constitutive Androstane Receptor induces hepatic lipogenesis and regulates Pnpla3 gene expression in a LXR-independent way. | 2016 | Details |
| A18370 | 27178444 | Liver Int | Advanced non-alcoholic fatty liver disease and adipose tissue fibrosis in patients with Alström syndrome. | 2016 | Details |
| A18378 | 27173514 | Environ Int | Association between exposures to brominated trihalomethanes, hepatic injury and type II diabetes mellitus. | 2016 | Details |
| A18386 | 27170389 | Dig Dis | Non-Alcoholic Steatohepatitis: From Pathophysiology to Novel Therapies. | 2016 | Details |
| A18387 | 27169860 | BMC Res Notes | Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease. | 2016 | Details |
| A18390 | 27166773 | Clinics (Sao Paulo) | FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism. | 2016 | Details |
| A18392 | 27166128 | Am J Gastroenterol | Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study. | 2016 | Details |
| A18398 | 27160697 | Dig Liver Dis | Non-alcoholic fatty liver disease fibrosis score and preclinical vascular damage in morbidly obese patients. | 2016 | Details |
| A18401 | 27157992 | Am J Pathol | Lipid-Induced Endoplasmic Reticulum Stress Impairs Selective Autophagy at the Step of Autophagosome-Lysosome Fusion in Hepatocytes. | 2016 | Details |
| A18402 | 27155918 | J Nutr Biochem | Intake of a Western diet containing cod instead of pork alters fatty acid composition in tissue phospholipids and attenuates obesity and hepatic lipid accumulation in mice. | 2016 | Details |
| A18403 | 27155553 | Clin Gastroenterol Hepatol | Exercise-based Interventions for Nonalcoholic Fatty Liver Disease: A Meta-analysis and Meta-regression. | 2016 | Details |
| A18409 | 27152734 | Curr Opin Clin Nutr Metab Care | Sugar and metabolic health: is there still a debate? | 2016 | Details |
| A18410 | 27152074 | Clujul Med | Prevention of NAFLD development in rats with obesity via the improvement of pro/antioxidant state by cerium dioxide nanoparticles. | 2016 | Details |
| A18418 | 27147819 | Integr Med Insights | The Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver Disease. | 2016 | Details |
| A18420 | 27146015 | Annu Rev Nutr | Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis. | 2016 | Details |
| A18422 | 27146012 | Annu Rev Nutr | Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus. | 2016 | Details |
| A18423 | 27145114 | Mol Nutr Food Res | Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice. | 2016 | Details |
| A18424 | 27145007 | Endocrinology | Maternal Hyperleptinemia Improves Offspring Insulin Sensitivity in Mice. | 2016 | Details |
| A18426 | 27143968 | Int J Endocrinol | Histopathologic Evaluation of Nonalcoholic Fatty Liver Disease in Hypothyroidism-Induced Rats. | 2016 | Details |
| A18428 | 27143495 | Prev Med | Impact of physical activity on nonalcoholic steatohepatitis in people with nonalcoholic simple fatty liver: A prospective cohort study. | 2016 | Details |
| A18432 | 27142672 | Dig Dis Sci | Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study. | 2016 | Details |
| A18436 | 27136390 | Mol Nutr Food Res | Nutritional depletion in n-3 PUFA in apoE knock-out mice: A new model of endothelial dysfunction associated with fatty liver disease. | 2016 | Details |
| A18441 | 27132506 | Oncogene | Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma. | 2016 | Details |
| A18445 | 29182821 | Rinsho Byori | [Present State of Non-B Non-C Liver Disease-and Its Monitoring.] | 2016 | Details |
| A18447 | 28891620 | Zhongguo Zhong Yao Za Zhi | [Experimental study of Tangshen formulain improved lipid metabolism and phenotypic switch of macrophage in db/db mice]. | 2016 | Details |
| A18448 | 27128911 | Int J Mol Sci | Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic Review. | 2016 | Details |
| A18449 | 27128907 | Int J Mol Sci | PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A18452 | 27125895 | AAPS J | Dual Outcomes of Rosiglitazone Treatment on Fatty Liver. | 2016 | Details |
| A18453 | 27124954 | Genome Med | Antibiotic perturbation of the murine gut microbiome enhances the adiposity, insulin resistance, and liver disease associated with high-fat diet. | 2016 | Details |
| A18455 | 27123846 | PLoS One | Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A18457 | 27122660 | World J Gastroenterol | Nonalcoholic fatty liver disease as a multi-systemic disease. | 2016 | Details |
| A18458 | 27121255 | Int J Obes (Lond) | Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice. | 2016 | Details |
| A18459 | 27121253 | Int J Obes (Lond) | Reduced circulating levels of sTWEAK are associated with NAFLD and may affect hepatocyte triglyceride accumulation. | 2016 | Details |
| A18462 | 27113292 | Nutr Metab Cardiovasc Dis | The innovative "Bio-Oil Spread" prevents metabolic disorders and mediates preconditioning-like cardioprotection in rats. | 2016 | Details |
| A18466 | 27110262 | Hepat Mon | Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. | 2016 | Details |
| A18470 | 27107966 | Best Pract Res Clin Obstet Gynaecol | Hepatic manifestations of women with polycystic ovary syndrome. | 2016 | Details |
| A18473 | 27105827 | Nutr J | Pathophysiological role of host microbiota in the development of obesity. | 2016 | Details |
| A18494 | 27091184 | Diabetologia | Diagnosis of non-alcoholic fatty liver disease (NAFLD). | 2016 | Details |
| A18495 | 27091156 | Cell Mol Life Sci | Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease. | 2016 | Details |
| A18500 | 27089408 | J Pediatr Endocrinol Metab | Low 25-hydroxyvitamin D level is not an independent risk factor for hepatosteatosis in obese children. | 2016 | Details |
| A18501 | 27089331 | Int J Mol Sci | NAFLD and Chronic Kidney Disease. | 2016 | Details |
| A18504 | 27086005 | Curr Gastroenterol Rep | Pediatric Non-alcoholic Fatty Liver Disease. | 2016 | Details |
| A18505 | 27085971 | Biochim Biophys Acta | BMP-9 enhances fibroblast growth factor 21 expression and suppresses obesity. | 2016 | Details |
| A18507 | 27085779 | Metabolism | Computerized tomography measured liver fat is associated with low levels of N-terminal pro-brain natriuretic protein (NT-proBNP). Multi-Ethnic Study of Atherosclerosis. | 2016 | Details |
| A18508 | 27085774 | Metabolism | Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity. | 2016 | Details |
| A18510 | 27083512 | J Gastroenterol Hepatol | Adiponectin regulates aquaglyceroporin expression in hepatic stellate cells altering their functional state. | 2017 | Details |
| A18511 | 27083404 | Obes Res Clin Pract | Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity. | 2016 | Details |
| A18517 | 27076758 | World J Gastroenterol | Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease. | 2016 | Details |
| A18518 | 27076501 | Hum Reprod | Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome. | 2016 | Details |